HomeBIAFW • NASDAQ
add
bioAffinity Technologies
Previous close
$0.13
Year range
$0.12 - $2.90
Market cap
5.40M USD
Avg Volume
626.00
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 1.85M | -22.97% |
Operating expense | 3.11M | 12.05% |
Net income | -2.66M | -35.61% |
Net profit margin | -143.53 | -76.05% |
Earnings per share | -0.16 | — |
EBITDA | -2.48M | -37.88% |
Effective tax rate | -0.33% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 444.71K | -81.87% |
Total assets | 5.55M | -31.08% |
Total liabilities | 4.11M | 47.12% |
Total equity | 1.44M | — |
Shares outstanding | 18.26M | — |
Price to book | 1.58 | — |
Return on assets | -108.91% | — |
Return on capital | -191.10% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -2.66M | -35.61% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2014
Headquarters
Website
Employees
57